1-15 of 851
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®Emerging Therapeutic Strategies in Metastatic NSCLC
Shared Decision-Making in Colorectal Cancer Screening
Clinician's RoundtableShared Decision-Making in Colorectal Cancer Screening
Turning Cold Tumors Hot With mRNA COVID-19 Vaccines
COVID-19: On The FrontlinesTurning Cold Tumors Hot With mRNA COVID-19 Vaccines
Improving Diagnostic Accuracy in Systemic Mastocytosis
Clinician's RoundtableImproving Diagnostic Accuracy in Systemic Mastocytosis
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®Real-World Strategies for Complex cGVHD Treatment Decisions
- advertisement
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Project Oncology®Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Addressing Barriers to CAR T Referral in R/R LBCL
Project Oncology®Addressing Barriers to CAR T Referral in R/R LBCL
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®Optimizing Multidisciplinary Care in Perioperative NSCLC
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Clinician's RoundtableBlood-Based Colorectal Cancer Screening: Where Do We Stand?
- advertisement
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Advancing Long-Term Outcomes in Systemic Mastocytosis: The Latest Research
Clinician's RoundtableAdvancing Long-Term Outcomes in Systemic Mastocytosis: The Latest Research
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer





















































































